New CEO at Cevec Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Cevec Pharmaceuticals, a Germany biopharmaceutical company specialising in the development of therapeutic proteins using their proprietary human cell expression systems, has appointed Dr Rainer Lichtenberger chief executive officer. He succeeds Professor Stefan Kochanek, one of the founders of the company, who has led the company as interim CEO for almost half a year and will continue to serve as one of the advisory board members. Dr Lichtenberger has 20 years' management experience in companies such as the Merckle/ratiopharm group and Merck KGaA.